Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease.
about
Xanthine oxidoreductase reference values in platelet-poor plasma and platelets in healthy volunteersAssociation between xanthine dehydrogenase tag single nucleotide polymorphisms and essential hypertension.Hyperuricemia and chronic kidney disease: an enigma yet to be solved.Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats.Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.Xanthine oxidase and uric acid as independent predictors of albuminuria in patients with diabetes mellitus type 2.
P2860
Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Circulating purine compounds, ...... n and end stage renal disease.
@en
Circulating purine compounds, ...... n and end stage renal disease.
@nl
type
label
Circulating purine compounds, ...... n and end stage renal disease.
@en
Circulating purine compounds, ...... n and end stage renal disease.
@nl
prefLabel
Circulating purine compounds, ...... n and end stage renal disease.
@en
Circulating purine compounds, ...... n and end stage renal disease.
@nl
P2093
P2860
P50
P1433
P1476
Circulating purine compounds, ...... on and end stage renal disease
@en
P2093
Boris Djindjic
Dijana Stojanovic
Marina Deljanin-Ilic
Milojkovic Boban
Milojkovic D Bobana
Radmila Pavlovic
Sonja Radenkovic
Stevan Ilic
Tatjana Jevtovic-Stoimenov
P2860
P304
P356
10.3109/0886022X.2014.882240
P577
2014-02-06T00:00:00Z